Leukapheresis Market to Grow at a CAGR of 8.7% to reach US$ 133.90 million from 2021 to 2028
[Research Report] The leukapheresis market is projected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.
Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields. Factors such as the rising number of voluntary blood donors, increasing incidence of hematologic diseases, and surging elderly population are fueling the leukapheresis market growth. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Leukapheresis Market: Strategic Insights
Market Size Value in US$ 74.48 Million in 2021 Market Size Value by US$ 133.90 Million by 2028 Growth rate CAGR of 8.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Leukapheresis Market: Strategic Insights
| Market Size Value in | US$ 74.48 Million in 2021 |
| Market Size Value by | US$ 133.90 Million by 2028 |
| Growth rate | CAGR of 8.7% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. The greatest surge in the number of voluntary blood donors was found in Southeast Asian countries (83%) and the Americas (70%).
National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. For example, in India, the National Blood Transfusion Council (NBTC), constituted within the National AIDS Control Organization (NACO), is the central body that coordinates with the State Blood Transfusion Councils (SBTCs), established within State AIDS Control Societies (SACS). The NBTC supports health programs for various activities related to blood transfusion services (BTS). Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.
Product Type-Based Insights
Based on product type, the leukapheresis market is bifurcated into leukapheresis devices and leukapheresis disposables. In 2021, the leukapheresis disposables segment held a larger market share. However, the leukapheresis devices segment is expected to register a higher CAGR during 2021 to 2028.
Application-Based Insights
The leukapheresis market, by application, is bifurcated into research applications and therapeutic applications. In 2021, the research applications segment held a larger share of the market and the same segment is expected to register a higher CAGR during the coming years.
End-User-Based Insights
The leukapheresis market, by end user, is segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers, and hospitals and transfusion centers. In 2021, the blood component providers and blood centers segment held the largest share of the market. On the other side, the hospitals and transfusion centers segment is expected to register the highest a CAGR during the coming years.
Companies operating in the leukapheresis market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.
Leukapheresis Market Report Scope
Leukapheresis Market – by Product Type
- Leukapheresis Devices
- Apheresis Devices
- Leukapheresis Columns and Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
Leukapheresis Market – by Application
- Research Applications
- Therapeutic Applications
Leukapheresis Market – by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Blood Component Providers and Blood Centres
- Hospitals and Transfusion Centers
Leukapheresis Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South America (SAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type , Application , and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.
Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.
The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.
The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.
Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.
Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Leukapheresis Market – By Product Type
1.3.2 Global Leukapheresis Market – By Application
1.3.3 Global Leukapheresis Market – By End User
1.3.4 Global Leukapheresis Market – By Geography
2. Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Leukapheresis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Number of Voluntary Blood Donors
5.1.2 Increasing Incidence of Hematologic Diseases
5.1.3 Surge in Elderly Population
5.2 Key Market Restraints
5.2.1 High Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Developments in Therapeutic Apheresis
5.5 Impact Analysis
6. Leukapheresis Market – Global Analysis
6.1 Global Leukapheresis Market Revenue Forecast and Analysis
6.2 Global Leukapheresis Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Leukapheresis Market Analysis and forecasts to 2028 – Product Type
7.1 Overview
7.2 Global Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2 Leukapheresis Columns and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis Columns and Cell Separators Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Mn)
8. Leukapheresis Market Analysis and Forecasts TO 2028 – Application
8.1 Overview
8.2 Global Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Mn)
9. Leukapheresis Market Analysis and Forecasts TO 2028 – End-User
9.1 Overview
9.2 Global Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Mn)
10. Global Leukapheresis Market – Geographic Analysis
10.1 North America: Leukapheresis Market
10.1.1 Overview
10.1.2 North America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.3.1 North America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.4 North America: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.5 North America: Leukapheresis Market, by End-User, 2019–2028 (USD Million)
10.1.6 North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.6.1.3.1 US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.6.1.4 US: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.6.1.5 US: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.6.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.6.2.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.6.2.5 Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.6.3 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)
10.1.6.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.6.3.5 Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2 Europe: Leukapheresis Market
10.2.1 Overview
10.2.2 Europe: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.3.1 Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.4 Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.5 Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2.6 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2.6.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.3 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.2.3.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.2.4 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.2.5 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2.6.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2.6.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)
10.2.6.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.2.6.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.2.6.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.2.6.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.2.6.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3 Asia Pacific: Leukapheresis Market
10.3.1 Overview
10.3.2 Asia Pacific: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.3.1 Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.1.3.1 China: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.1.4 China: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.1.5 China: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.2.3.1 Japan: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.2.4 Japan: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.2.5 Japan: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6.3 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.3.4 India: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.3.5 India: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6.4 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 Australia: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.4.3.1 Australia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.4.4 Australia: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.4.5 Australia: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6.5 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 South Korea: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.5.3.1 South Korea: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.5.4 South Korea: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.5.5 South Korea: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.3.6.6.5 Rest of Asia Pacific: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.4 Middle East & Africa: Leukapheresis Market
10.4.1 Overview
10.4.2 Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.4.3.1 Middle East & Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.4.4 Middle East & Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.4.5 Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3.1 Saudi Arabia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.4.6.1.4 Saudi Arabia: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.4.6.1.5 Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 Overview
10.4.6.2.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3.1 UAE: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.4.6.2.4 UAE: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.4.6.2.5 UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3.1 South Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.4.6.3.4 South Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.4.6.3.5 South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3 Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3.1 Rest of Middle East and Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.4.6.4.5 Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Leukapheresis Market
10.5.1 Overview
10.5.2 South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.5.3.1 South and Central America Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.5.5 South and Central America: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.5.6 South and Central America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.5.6.1.2.1 Brazil: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.5.6.1.3 Brazil: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.5.6.1.4 Brazil: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.5.6.2 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.5.6.2.2.1 Argentina: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.5.6.2.3 Argentina: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.5.6.2.4 Argentina: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.5.6.3.2.1 Rest of South and Central America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Leukapheresis Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Leukapheresis Market– Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Leukapheresis Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 6. US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 18. Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 19. Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Europe Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 22. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 23. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 26. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 27. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 28. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 30. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 31. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 32. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 34. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)
Table 35. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 36. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 38. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 39. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 40. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 44. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 49. China: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 50. China Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 51. China Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. China: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 57. India: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 58. India Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 59. India Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. India: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Australia: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 80. Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 81. UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 82. UAE Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 83. UAE Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 84. UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 88. South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East and Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East and Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 96. South and Central America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Brazil Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 104. Argentina Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of South and Central America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of South and Central America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done by Companies
Table 110. Inorganic Developments Done by Companies
Table 111. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Leukapheresis Market Segmentation
Figure 2. Leukapheresis Market Segmentation, By Region
Figure 3. Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Leukapheresis Market, by Geography (US$ Million)
Figure 7. Global Leukapheresis Market – Leading Country Markets (US$ Million)
Figure 8. Global Leukapheresis Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Leukapheresis market impact analysis of driver and restraints
Figure 15. Global Leukapheresis Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Leukapheresis Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Leukapheresis Market
Figure 18. Global Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 19. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Leukapheresis Columns and Cell Separators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 25. Research Applications Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Global Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. North America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. North America Leukapheresis Market Revenue and Forecast to 2028 (USD Million)
Figure 34. North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 35. US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 39. Europe Leukapheresis Market Revenue and Forecast to 2028 (USD Million)
Figure 40. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 41. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Asia Pacific: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 48. Asia Pacific Leukapheresis Market Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia Pacific: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 50. China: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Japan: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. India: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Australia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. South Korea: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Rest of Asia Pacific: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Middle East & Africa: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 57. Middle East & Africa Leukapheresis Market Revenue and Forecast to 2028 (USD Million)
Figure 58. Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 59. Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Middle East and Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. South and Central America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. South and Central America Leukapheresis Market Revenue and Forecast to 2028 (USD Million)
Figure 65. South and Central America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 66. Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of South and Central America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 1. Impact of COVID-19 Pandemic in North American Country Markets
Figure 2. Impact of COVID-19 Pandemic in European Country Markets
Figure 3. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 4. Impact Of COVID-19 Pandemic In Middle East and Africa Market
Figure 5. Impact Of COVID-19 Pandemic In South and Central America Market
Figure 6. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Leukapheresis Market
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For